COL11A1 and ovarian cancer: Similarly, etomoxir treatment significantly reduced COL11A1-induced NADH levels in OVCAR3 cells (Fig. S2C), suggesting that COL11A1 increases ATP and NADPH production through FAO in ovarian cancer cells.